Manetta A, Satyaswaroop P G, Hamilton T, Ozols R, Mortel R
Department of Obstetrics and Gynecology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Gynecol Oncol. 1987 Nov;28(3):292-9. doi: 10.1016/0090-8258(87)90175-2.
Human ovarian carcinomas in nude mice were radioimaged using a well-characterized antibody against a tumor-associated antigen (CA 125) and three transplantable human ovarian carcinoma tumor lines: NIH:OVCAR 3, NIH:OVCAR 5, and NIH:OVCAR 9. Radioiodinated monoclonal antibody OC125 was used in these studies. In order to establish the optimal conditions for imaging, tumor/blood ratios were determined. Gamma scintigraphy of nude mice bearing subcutaneous transplants of human ovarian carcinomas 3-4 days after 131I-OC125 administration demonstrated selective localization of the radiolabeled monoclonal antibody by these tumors without need for any background subtraction techniques.
使用一种针对肿瘤相关抗原(CA 125)的特性明确的抗体以及三种可移植的人卵巢癌肿瘤系:NIH:OVCAR 3、NIH:OVCAR 5和NIH:OVCAR 9,对裸鼠体内的人卵巢癌进行放射性成像。这些研究中使用了放射性碘化单克隆抗体OC125。为了确定成像的最佳条件,测定了肿瘤/血液比率。在给予131I-OC125后3 - 4天,对皮下移植有人卵巢癌的裸鼠进行γ闪烁显像,结果显示这些肿瘤能选择性地摄取放射性标记的单克隆抗体,无需任何背景扣除技术。